Published in Journal of the American Academy of Dermatology
History of high cholesterol level was not associated with skin cancer risk. Longer duration of statin use was associated with a trend toward higher BCC risk in men.
Published in Journal of the American Academy of Dermatology
Patients with HS with risk factors, signs, or symptoms of T2DM should be screened.
Published in Journal of the American Academy of Dermatology
Antihistamines are widely used for the treatment of AD. There is no high-level evidence to suggest that nonsedating antihistamines reduce itch in patients with AD or that sedating antihistamines provide benefit in controlling AD symptoms (except perhaps sleep and AD comorbidities, such as allergic rhinitis).
Published in Journal of the American Academy of Dermatology
The interaction between sex and UVI is age-dependent. The female sex is an independent risk factor for early onset melanoma, but the female sex also protects against UV-associated melanoma in older age groups.
Published in Journal of the American Academy of Dermatology
Significant health disparities exist among under-represented minorities in the Unites States, which can partially be accounted for by the quality of patient-physician interaction. A distinguishing factor of this interaction is the ability of the provider to demonstrate cultural competence, or address the social, cultural, and community influences o...
Published in Journal of the American Academy of Dermatology
Pediatric psoriasis is associated with higher odds of multiple cardiovascular comorbidities among hospitalized patients. Strategies for mitigating excess cardiovascular risk in pediatric psoriasis need to be determined.
Published in Journal of the American Academy of Dermatology
The UD sign significantly improved accuracy and specificity of MM recognition. We recommend adding the UD sign to patient education in addition to the traditional ABCDE rule.
Published in Journal of the American Academy of Dermatology
KEY TEACHING POINTS.
Published in Journal of the American Academy of Dermatology
A prediction rule was developed and validated to identify patients unlikely to respond adequately to methotrexate. The rule indicates that 4 weeks of methotrexate might be sufficient to predict long-term response with limited safety risk.
Published in Journal of the American Academy of Dermatology
Our findings suggest disparities in health care utilization for eczema among non-Hispanic black children despite utilization patterns suggestive of more severe disease.
